Elsevier

Brain Research

Volume 1712, 1 June 2019, Pages 16-24
Brain Research

Research report
Delivery of different genes into presynaptic and postsynaptic neocortical neurons connected by a BDNF-TrkB synapse

https://doi.org/10.1016/j.brainres.2019.01.038Get rights and content

Highlights

  • Different genes were delivered into neurons connected by BDNF-TrkB synapses.

  • A synthetic peptide neurotransmitter containing BDNF and the His tag was developed.

  • This peptide neurotransmitter is designed to bind to TrkB on postsynaptic neurons.

  • Antibody-mediated, targeted gene transfer to postsynaptic neurons used anti-His tag.

  • The roles of neurons connected by BDNF-TrkB synapses may now be studied.

Abstract

Brain-Derived Neurotrophic Factor (BDNF) signaling through TrkB receptors has important roles in synapse formation, synaptic plasticity, learning, and specific diseases. However, it is challenging to relate BDNF-TrkB synapses to circuit physiology or learning, as BDNF-TrkB synapses are embedded in complex circuits that contain numerous neuron and synapse types. Thus, analyzing the physiology of neurons connected by BDNF-TrkB synapses would be advanced by a technology to deliver different genes into presynaptic and postsynaptic neurons, connected by a BDNF-TrkB synapse. Here, we report selective gene transfer across BDNF-TrkB synapses: The model system was the large projection from rat postrhinal to perirhinal cortex. The first gene transfer, into presynaptic neurons in postrhinal cortex, used a virus vector and standard gene transfer procedures. This vector expresses a synthetic peptide neurotransmitter composed of three domains, a dense core vesicle sorting domain, BDNF, and the His tag. Upon release, this peptide neurotransmitter binds to TrkB receptors on postsynaptic neurons. The second gene transfer, into connected postsynaptic neurons in perirhinal cortex, uses antibody-mediated, targeted gene transfer and an anti-His tag antibody, as the synthetic peptide neurotransmitter contains the His tag. Confocal microscope images showed that using untargeted gene transfer, only 10–15% of the transduced presynaptic axons were proximal to a transduced postsynaptic dendrite. But using targeted gene transfer, ∼70% of the transduced presynaptic axons were proximal to a transduced postsynaptic dendrite. This technology may support studies on the roles of neurons connected by BDNF-TrkB synapses in circuit physiology and learning.

Introduction

Signaling across specific synapses by Brain-Derived Neurotrophic Factor (BDNF) release and subsequent binding to the TrkB receptor plays critical roles in the formation of synapses, synaptic plasticity, long-term potentiation (LTP), learning, and specific diseases (Panja and Bramham, 2014, Yoshii and Constantine-Paton, 2010, Zhao et al., 2017). Of note, in the hippocampus or neocortex, BDNF to TrkB signaling is required for specific types of synaptic plasticity, including LTP, and is associated with specific learning tasks (Egan et al., 2003, Lu, 2003, Patterson et al., 1996). These observations suggest that BDNF to TrkB signaling across specific synapses has an essential role in the synaptic plasticity that supports learning specific tasks. But studies on these issues are challenging because BDNF-TrkB synapses are embedded in complex forebrain circuits, and only a fraction of the synapses are BDNF-TrkB synapses. Forebrain areas contain hundreds to thousands of neuron types, and each type forms precise connections with other neuron types, to support circuit physiology (Dudai, 1989). More specifically, a neocortical column contains at least tens, and probably hundreds, of neuron types, that form precise synaptic connections both within the column and to other areas, and each type of connection likely supports specific physiological functions (Peters and Jones, 1984, Sugino et al., 2006). Of note, current genetic approaches to analyzing circuits and behaviors, including optogenetics or activation of specific signaling or transcriptional pathways, are typically applied to an entire circuit (Dymecki and Kim, 2007, Fenno et al., 2011, Luo et al., 2008, Zhang et al., 2005). Thus, elucidating the role of BDNF to TrkB signaling for synaptic plasticity and learning would benefit from a gene transfer technology that can selectively deliver different genes into the presynaptic and postsynaptic neurons that form a BDNF-TrkB synapse.

For the model system to develop gene transfer selectively across BDNF-TrkB synapses, we used the large projection from postrhinal (POR) cortex to perirhinal (PER) cortex (Burwell and Amaral, 1998b), as this synapse plays an important role in visual object learning, and likely uses BDNF to TrkB signaling across some synapses. POR cortex is required for this learning (Murray et al., 2007, Zhang et al., 2010a), receives afferents from visual areas, and sends efferents to multiple neocortical areas, including PER cortex (Agster and Burwell, 2009, Burwell and Amaral, 1998a). We developed a genetic intervention that targets some of the essential information for this learning to the genetically-modified circuit: Activation of protein kinase C (PKC) pathways in several hundred glutamatergic and GABAergic neurons in POR cortex (via a virus vector) increases activation-dependent release of GABA and glutamate, and supports more accurate learning of new visual object discriminations (Zhang et al., 2005, Zhang et al., 2012c). Some of the essential information for this learning is encoded in the genetically-modified circuit: After gene transfer and learning, small neurochemical lesions that ablate the genetically-modified circuit selectively reduce performance for discriminations learned after gene transfer (Zhang et al., 2010a). Correlatively, this circuit is preferentially activated during this learning (Zhang et al., 2005, Zhang et al., 2010a).

Established genetic technologies for mapping circuits or visualizing synapses support numerous informative experiments, but lack the capability to selectively deliver different genes across a BDNF-TrkB synapse. Anterograde or retrograde projections, across one, or a series, of synapses have been mapped using specific viruses, including Sindbis Virus, Vesicular Stomatitis Virus, Pseudorabies Virus, Rabies Virus, and Herpes Simplex Virus (HSV-1) (reviewed in (Lo and Anderson, 2011)). These technologies deliver the same genes into the presynaptic and postsynaptic neurons, as they use a single virus that spreads across the affected synapses. Synapses between specific neurons have been visualized using mGRASP, but this technology does not selectively deliver genes into connected neurons, as it uses untargeted gene transfer, and lacks synapse type specificity (Feng et al., 2014, Kim et al., 2011). A Rabies Virus-based technology can deliver a gene into postsynaptic neurons, and then deliver a different gene into all the presynaptic neurons (Osakada et al., 2011), but requires a specific transgenic mouse and a specific rabies virus, lacks specificity for synapse type, and physiologically useful expression is limited to 5–11 days after gene transfer, as Rabies Virus is neurotoxic (Osakada et al., 2011). We developed a technology that can deliver a gene across specific glutamatergic synapses; the presynaptic neurons express a synthetic peptide neurotransmitter that binds to NMDA receptors, and antibody-mediated targeted gene transfer delivers a gene selectively into neurons that bind the synthetic peptide neurotransmitter (Zhang et al., 2012b).

In rat visual cortex, a subset of the glutamatergic neurons also express TrkB, as shown by costaining with an anti-TrkB antibody and antibodies that recognize specific NMDA receptor subunits (Tongiorgi et al., 1999). These results suggest that in PER cortex, a subset of the glutamatergic synapses are also BDNF-TrkB synapses. Thus, it appears likely that targeting gene transfer across BDNF-TrkB synapses would provide additional specificity compared to targeting gene transfer across all glutamatergic synapses.

Here, we report a gene transfer technology that can deliver one gene into presynaptic neurons and a second gene into neurons that are connected via a BDNF-TrkB synapse, by using a synthetic peptide neurotransmitter that binds to TrkB receptors. This technology was established by delivering a first gene into presynaptic neurons in POR cortex, and then delivering a second gene selectively across BDNF-TrkB synapses into postsynaptic neurons in PER cortex. This technology should be useful for analyzing the role of BDNF-TrkB synapses in synaptic plasticity and learning.

Section snippets

The strategy for targeting gene transfer to neurons that are connected by a specific type of synapse

The strategy contains three steps (Fig. 1): The first gene transfer is into the presynaptic neurons in POR cortex, using standard gene transfer procedures; the vector particles are injected into POR cortex. This HSV-1 vector, the presynaptic vector, expresses a synthetic peptide neurotransmitter that contains three domains. The first domain is a dense core vesicle (DCV) sorting domain (Dikeakos and Reudelhuber, 2007) that supports processing and release of the recombinant protein as a peptide

Discussion

We have developed a novel technology to selectively deliver different genes into presynaptic and postsynaptic neurons that are connected by a BDNF-TrkB synapse. The first gene transfer delivered a specific gene into excitatory presynaptic neurons, and the second gene transfer delivered a different gene into an identified subset of their postsynaptic neurons that are connected by a BDNF-TrkB synapse, and in a specific brain area. The presynaptic vector expresses a synthetic peptide

Conclusions

We have developed a technology to deliver different genes into presynaptic and postsynaptic neurons connected by BDNF-TrkB synapses. This technology is based on a synthetic peptide neurotransmitter that contains a DCV sorting domain, so the peptide is processed as a peptide neurotransmitter, BDNF, to bind to TrkB receptors, and the His tag, to support antibody-mediated, targeted gene transfer. In the model system, the large projection from POR cortex to PER cortex, this technology increased the

Materials

OptiMEM, penicillin/streptomycin, Dulbecco’s modified minimal essential medium (DMEM), and fetal bovine serum (FBS) were obtained from Invitrogen; G418 was obtained from RPI. The primary antibodies were mouse anti-His tag (for targeting, Qiagen), rabbit anti-His tag (for immunohistochemistry, Cell Signaling), mouse anti-GFP (Thermofisher Scientific), and mouse anti-flag (Sigma). Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG and Texas red-conjugated goat anti-rabbit IgG were

Acknowledgments

We thank Dr. Hui Zhao for assistance with the packaging procedure. This work was supported by NIH Grant NS086960 (AIG). Assistance from the Research to Prevent Blindness and the Lions Eye Foundation is gratefully acknowledged.

References (63)

  • H. Kameda

    Targeting green fluorescent protein to dendritic membrane in central neurons

    Neurosci. Res.

    (2008)
  • M. Kozak

    Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

    Cell

    (1986)
  • L. Lo et al.

    A cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons

    Neuron

    (2011)
  • L. Luo et al.

    Genetic dissection of neural circuits

    Neuron

    (2008)
  • J.R. Moskal

    GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator

    Neuropharmacology

    (2005)
  • F. Osakada

    New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits

    Neuron

    (2011)
  • D. Panja et al.

    BDNF mechanisms in late LTP formation: a synthesis and breakdown

    Neuropharmacology. 76 Pt

    (2014)
  • S.L. Patterson

    Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice

    Neuron

    (1996)
  • M. Rasmussen

    Glutamatergic or GABAergic neuron-specific, long-term expression in neocortical neurons from helper virus-free HSV-1 vectors containing the phosphate-activated glutaminase, vesicular glutamate transporter-1, or glutamic acid decarboxylase promoter

    Brain Res.

    (2007)
  • I.L. Smith et al.

    Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression

    Virology

    (1992)
  • E. Tongiorgi et al.

    Co-expression of TrkB and the N-methyl-D-aspartate receptor subunits NR1-C1, NR2A and NR2B in the rat visual cortex

    Neuroscience

    (1999)
  • T. Yang

    Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion

    Molec. Brain. Res.

    (2001)
  • G. Zhang

    A tyrosine hydroxylase–neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors

    Molec. Brain. Res.

    (2000)
  • G. Zhang

    Genetic labeling of both the axons of transduced, glutamatergic neurons in rat postrhinal cortex and their postsynaptic neurons in other neocortical areas by Herpes Simplex Virus vectors that coexpress an axon-targeted ß-galactosidase and wheat germ agglutinin from a vesicular glutamate transporter-1 promoter

    Brain Res.

    (2010)
  • G. Zhang et al.

    A helper virus-free HSV-1 vector containing the vesicular glutamate transporter-1 promoter supports expression preferentially in VGLUT1-containing glutamatergic neurons

    Brain Res.

    (2010)
  • G. Zhang

    The vesicular glutamate transporter-1 upstream promoter and first intron each support glutamatergic-specific expression in rat postrhinal cortex

    Brain Res.

    (2011)
  • G. Zhang

    Overexpression of either lysine-specific demethylase-1 or CLOCK, but not Co-Rest, improves long-term expression from a modified neurofilament promoter, in a helper virus-free HSV-1 vector system

    Brain Res.

    (2012)
  • G. Zhang

    Targeted gene transfer of different genes to presynaptic and postsynaptic neocortical neurons connected by a glutamatergic synapse

    Brain Res.

    (2012)
  • G. Zhang

    Neurons can be labeled with unique hues by helper virus-free HSV-1 vectors expressing Brainbow

    J. Neurosci. Methods

    (2015)
  • H. Zhao

    Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments

    Brain Res.

    (2017)
  • K.L. Agster et al.

    Cortical efferents of the perirhinal, postrhinal, and entorhinal cortices of the rat

    Hippocampus.

    (2009)
  • Cited by (5)

    • Connected neurons in multiple neocortical areas, comprising parallel circuits, encode essential information for visual shape learning

      2021, Journal of Chemical Neuroanatomy
      Citation Excerpt :

      Also, the neuron type(s) is not known for the critical neurons in either PER cortex or TEv, as pol III promoter expressing Syt I siRNA is active in most cell types, and neocortical projection neurons form synapses with both glutamatergic and GABAergic neurons. Further information about the critical neuron types could be obtained by using the present experimental design, with a synthetic peptide neurotransmitter that is specific for TrkB-, or mGluR5-, or NR2B-containing synapses (Nagayach et al., 2019a, b; Nagayach et al., 2019c), or using a promoter system that restricts expression of the Syt I siRNA to specific neuron types. The present study showed that during performance, the transduced neurons in PER cortex contain elevated levels of both CREB activity and dendritic protein synthesis.

    • Efficient gene transfers into neocortical neurons connected by NMDA NR1-containing synapses

      2019, Journal of Neuroscience Methods
      Citation Excerpt :

      We changed the NR1 targeting domain to target gene transfer to receptors present in only specific subsets of glutamatergic synapses. We inserted BDNF to target to TrkB receptors, and we used ScFv that recognize either NR2B or mGluR5 (Nagayach et al., 2019b, 2019c, 2019d). These new synthetic peptide neurotransmitters were tested in the same model system used here, and supported 70–80 % targeting to each cognate receptor.

    View full text